Improved MR Detection of Optic Nerve Demyelination With MP2RAGE-FLAWS Compared With T 2 -Weighted Fat-Saturated

Randa Aichour1, Thibaut Emorine, Nadia Oubaya

  • 1From the Department of Neuroradiology, AP-HP, Henri Mondor University Hospital, Créteil, France (R.A., T.E., I.M., B.B.); University Paris Est Créteil, INSERM, IMRB, Créteil, France (N.O.); Department of Public Health, AP-HP, Henri Mondor University Hospital, Créteil, France (N.O.); EA 4391, Université Paris Est Créteil, Créteil, France (A.C., B.B.); Department of Neurology, AP-HP, Henri Mondor University Hospital, Créteil, France (A.C.); Department of Neuroradiology, A. Rothschild Foundation Hospital, Paris, France (A.L.); Paris Cité University, Paris, France (A.L.); Advanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland (T.K.); Department of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland (T.K.); Signal Processing Laboratory (LTS 5), École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland (T.K.); and Siemens Healthcare SAS, Courbevoie, France (A.M.).

Investigative Radiology
|November 27, 2024
PubMed
Abstract

Insights

Compressed sensing-accelerated MP2RAGE-FLAWS MRI significantly improves optic nerve (ON) demyelination detection compared to standard T2-w fat-saturated imaging. This advanced sequence offers higher sensitivity, particularly in the intraorbital segment, aiding in diagnosing demyelinating diseases.

Area of Science:

  • Neuroimaging
  • Radiology
  • Multiple Sclerosis Research

Background:

  • Nonenhanced T1-weighted sequences like MP2RAGE and FLAWS are effective for brain and cervical spine demyelination in multiple sclerosis.
  • The utility of these sequences for detecting optic nerve (ON) demyelination has not been previously evaluated.
  • Optic nerve involvement is a common manifestation of demyelinating diseases, impacting visual function.

Purpose of the Study:

  • To assess the performance of compressed sensing-accelerated (CS) MP2RAGE-FLAWS imaging for detecting optic nerve (ON) demyelination.
  • To compare the efficacy of CS-MP2RAGE-FLAWS with conventional T2-weighted fat-saturated (FS) TSE imaging in a clinical setting.
  • To evaluate lesion detection sensitivity and specificity in different segments of the optic nerve.

Main Methods:

  • Retrospective analysis of MRI scans from patients with central nervous system demyelinating disorders (January-December 2022).
  • Inclusion criteria: simultaneous acquisition of brain CS-MP2RAGE-FLAWS and axial/coronal T2-w FS orbital sequences.
  • Four-step radiological analysis with blinded and consensus readings; reference standard was final radiologist assessment. Sensitivity and specificity calculated using McNemar's test.

Main Results:

  • Thirty-nine patients (34 with MS, 2 MOGAD, 1 NMOSD, 2 indeterminate) were analyzed, evaluating 78 optic nerves.
  • CS-MP2RAGE-FLAWS detected 64 lesions (41 nerves) versus 37 lesions (27 nerves) with 2D T2-w FS imaging.
  • CS-MP2RAGE-FLAWS showed significantly higher sensitivity (97.5% vs. 67.5%, P=0.001) without compromising specificity, especially in intraorbital and intracanalicular segments.

Conclusions:

  • CS-MP2RAGE-FLAWS imaging significantly enhances the detection of optic nerve demyelination compared to standard 2D T2-w FS sequences.
  • The improved detection is most notable in the intraorbital segment of the optic nerve.
  • This advanced sequence provides simultaneous whole-brain and cervical spinal cord imaging, offering efficiency without additional time cost.